Holista Colltech Limited (ASX:HCT)

Market Cap	12.29M
Revenue (ttm)	5.60M
Net Income (ttm)	-84.21K
Shares Out	285.77M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,359,267
Average Volume	329,836
Open	0.0430
Previous Close	0.0430
Day's Range	0.0420 - 0.0570
52-Week Range	0.0040 - 0.0570
Beta	0.64
RSI	80.67
Earnings Date	May 30, 2025

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2024, Holista Colltech's revenue was 5.60 million, a decrease of -5.86% compared to the previous year's 5.95 million. Losses were -84,214, -98.25% less than in 2023.